Published in Laryngoscope on December 01, 1999
Deafness and cochlear fibrocyte alterations in mice deficient for the inner ear protein otospiralin. Mol Cell Biol (2005) 1.09
Abnormal basement membrane in the inner ear and the kidney of the Mpv17-/- mouse strain: ultrastructural and immunohistochemical investigations. Histochem Cell Biol (2005) 0.90
Immunohistochemical distribution of basement membrane proteins in the human inner ear from older subjects. Hear Res (2009) 0.86
The pre- and post-somatic segments of the human type I spiral ganglion neurons--structural and functional considerations related to cochlear implantation. Neuroscience (2014) 0.85
Expression and function of scleraxis in the developing auditory system. PLoS One (2013) 0.75
Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res (1998) 1.58
Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem Biophys Res Commun (2000) 1.46
Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol (2001) 1.19
Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population. Hum Mutat (2001) 1.12
Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology (2001) 1.10
Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res (2002) 1.06
Acute cerebellitis with near-fatal cerebellar swelling and benign outcome under conservative treatment with high dose steroids. Eur J Paediatr Neurol (1998) 1.04
[Clinical characterization of patients with idiopathic sudden sensorineural hearing loss]. Laryngorhinootologie (2008) 0.98
Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus. Neuromuscul Disord (2001) 0.98
Tissue specific levels of glucocorticoid receptor within the rat inner ear. Hear Res (1993) 0.96
Megalencephaly, mega corpus callosum, and complete lack of motor development: a previously undescribed syndrome. Am J Med Genet (1998) 0.95
Connexin31-deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing and skin differentiation. Dev Biol (2001) 0.95
Distinct thyroid hormone-dependent expression of TrKB and p75NGFR in nonneuronal cells during the critical TH-dependent period of the cochlea. J Neurobiol (1999) 0.94
Clinical findings and a therapeutic trial in the first patient with beta-ureidopropionase deficiency. Neuropediatrics (2006) 0.91
Hereditary motor and sensory neuropathy--Lom (HMSNL): refined genetic mapping in Romani (Gypsy) families from several European countries. Neuromuscul Disord (2000) 0.86
Dynamics of Na,K-ATPase sites in lateral cochlear wall tissues of the rat. Eur Arch Otorhinolaryngol (1993) 0.84
In vitro effects of hydrogen peroxide on the cochlear neurosensory epithelium of the guinea pig. Hear Res (2000) 0.83
[Intralabyrinthine schwannomas]. HNO (2011) 0.82
Postnatal expression of the alpha-thyroid hormone receptor in the rat cochlea. Hear Res (1997) 0.82
[Myositis of the sternocleidomastoid muscle as a result of arthritis of the sternoclavicular joint]. Laryngorhinootologie (2006) 0.81
Glucocorticoid receptor expression in the postnatal rat cochlea. Hear Res (1995) 0.80
[Ear diseases and diabetes mellitus]. HNO (2014) 0.78
Effect of stress on cochlear glucocorticoid protein: acoustic stress. Hear Res (1995) 0.78
Response of the stria vascularis to corticosteroids. Laryngoscope (1991) 0.78
[Smoking behaviour after laryngectomy]. Laryngorhinootologie (2009) 0.78
[Case report of epithelioid hemangioendothelioma of the frontal region metastatic to the parotid gland]. Laryngorhinootologie (1998) 0.77
[Muramidase and lactoferrin in adenoidal hypertrophies, hypertrophic and chronic infected tonsil tissue--a quantitative analysis]. Laryngorhinootologie (2005) 0.76
Development of 11 beta-hydroxysteroid dehydrogenase expression in the rat cochlea. Acta Otolaryngol (1997) 0.76
[Endovascular treatment of epistaxis of the internal carotid artery. Vessel occlusion and vessel preservation]. HNO (2009) 0.75
[Bilateral auditory canal squamous cell carcinoma]. HNO (2006) 0.75
[Silicone as a foreign body in the middle ear: a rare complication after taking an impression of the auditory canal]. HNO (2007) 0.75
[S1 Clinical guideline"adenoids and adenoidectomy"]. HNO (2012) 0.75
[Hearing loss caused by high dose carboplatin therapy]. Laryngorhinootologie (1998) 0.75
Modulation of the rat stria vascularis in the absence of circulating adrenocorticosteroids. Acta Otolaryngol (1991) 0.75
[Secondary laryngeal malignancy: a laryngeal tumor of unexpected origin]. Laryngorhinootologie (2013) 0.75
["Triggered magnetic resonance tomography". A new procedure for imaging soft tissue movement in dysphagia (initial results)]. HNO (1994) 0.75
[Diagnosis and therapy of thyroid tissue of the base of the tongue]. HNO (1996) 0.75
[An unusual cervical tumor]. HNO (2014) 0.75
Expression of Na+,K(+)-ATPase alpha 1 subunit mRNA in the developing rat cochlea. Hear Res (1994) 0.75
["Ear camp" for children in Namibia. A field report]. HNO (2006) 0.75
[Congenital hearing loss. Molecular genetic diagnosis of connexin genes and genetic counselling]. HNO (2005) 0.75
[Immunohistochemical detection of humoral autoantibodies in patients with hearing loss in the last hearing ear]. Laryngorhinootologie (2000) 0.75